Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2008-5-14
pubmed:abstractText
We investigated the effect of angiotensin II (AII) type 1 (AT1) and angiotensin II type 2 (AT2) receptor blockers on tumour necrosis factor alpha (TNF-alpha)-induced cell damage in human renal proximal tubular epithelial cells (RPTEC).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 1 Receptor..., http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 2 Receptor..., http://linkedlifedata.com/resource/pubmed/chemical/CASP3 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/CASP7 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/CYBA protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Caspase 3, http://linkedlifedata.com/resource/pubmed/chemical/Caspase 7, http://linkedlifedata.com/resource/pubmed/chemical/Glucosamine, http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles, http://linkedlifedata.com/resource/pubmed/chemical/L-Lactate Dehydrogenase, http://linkedlifedata.com/resource/pubmed/chemical/N-acetylglucopyranosylamine, http://linkedlifedata.com/resource/pubmed/chemical/NADPH Oxidase, http://linkedlifedata.com/resource/pubmed/chemical/PD 123319, http://linkedlifedata.com/resource/pubmed/chemical/Pyridines, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Angiotensin, Type 2, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor..., http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha, http://linkedlifedata.com/resource/pubmed/chemical/Valine, http://linkedlifedata.com/resource/pubmed/chemical/olmesartan, http://linkedlifedata.com/resource/pubmed/chemical/valsartan
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1440-1797
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
309-15
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:18331441-Angiotensin II Type 1 Receptor Blockers, pubmed-meshheading:18331441-Angiotensin II Type 2 Receptor Blockers, pubmed-meshheading:18331441-Apoptosis, pubmed-meshheading:18331441-Caspase 3, pubmed-meshheading:18331441-Caspase 7, pubmed-meshheading:18331441-Cell Survival, pubmed-meshheading:18331441-Cells, Cultured, pubmed-meshheading:18331441-Cytoprotection, pubmed-meshheading:18331441-Dose-Response Relationship, Drug, pubmed-meshheading:18331441-Enzyme Activation, pubmed-meshheading:18331441-Epithelial Cells, pubmed-meshheading:18331441-Glucosamine, pubmed-meshheading:18331441-Humans, pubmed-meshheading:18331441-Imidazoles, pubmed-meshheading:18331441-Kidney Tubules, Proximal, pubmed-meshheading:18331441-L-Lactate Dehydrogenase, pubmed-meshheading:18331441-NADPH Oxidase, pubmed-meshheading:18331441-Pyridines, pubmed-meshheading:18331441-Receptor, Angiotensin, Type 2, pubmed-meshheading:18331441-Receptors, Tumor Necrosis Factor, Type I, pubmed-meshheading:18331441-Tetrazoles, pubmed-meshheading:18331441-Tumor Necrosis Factor-alpha, pubmed-meshheading:18331441-Valine
pubmed:year
2008
pubmed:articleTitle
Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells.
pubmed:affiliation
Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Nankoku, Japan. kagawat@kochi-u.ac.jp
pubmed:publicationType
Journal Article